Navigation Links
Too Much Sugar on the Menu? A New Tablet Might Someday Block Those Carbs

MANCHESTER, N.H., Nov. 5, 2013 /PRNewswire/ -- Sugar is everywhere—especially in the packaged and processed foods that have become a staple of today's American diet. Besides sugar, sweeteners lurk on many nutrition labels under the guises of brown rice syrup, fructose, glucose, corn sweetener, maltodextrin and evaporated cane juice, among others. According to the U.S. Department of Agriculture, Americans today eat 43 pounds of caloric sweeteners per year—39 percent more than they did in the 1950s. Consumers should be aware that the absence of sugar on an ingredient list doesn't mean it's not there.

Because sugar consumption has been linked to weight gain and obesity, heart disease, Type 2 diabetes, high blood pressure, depression and mood swings, watching one's sugar intake can be essential to good health. According to the American Heart Association (AHA), common sources of sugar include candy, cookies and ice cream; less obvious sources include condensed milk, canned peaches and cinnamon raisin bagels. The AHA advises that for most men and women, sugar consumption should be capped at 150 and 100 calories per day, respectively. The AHA also advises people to be careful with beverage selection; although soft drinks are an obvious source of sugar, many "better for you" beverages—like sports drinks and fruit drinks—also sneak in sugar. The best thing to do is stick with water.

Given that humans don't always make the best choices, there is another tool being developed that people with diabetes and pre-diabetes—as well as consumers concerned about high blood sugar or carbohydrate intake—should know about. It's called PAZ320 and it's a non-systemic, non-toxic, chewable drug candidate for people with Type 2 diabetes to better manage their blood sugar. The compound, which is currently undergoing testing in clinical trials, is being developed by Boston Therapeutics, Inc., a Manchester, NH pharmaceutical company.

David Platt, an expert in carbohydrate chemistry and CEO of Boston Therapeutics, says, "Everyone needs to make better nutritional choices, but being human, that is not always what happens. That's where PAZ320 might help. Taken before meals, clinical studies show that 45 percent of the study group showed an average 40 percent reduction in blood glucose levels after meals."

If it is approved by the FDA, PAZ320 might one day become an option to consider for people living with diabetes.

For more, visit, who paid for the writing and dissemination of this release.

Contact: Laura Radocaj, Dian Griesel Int'l., 212.825.3210

SOURCE Boston Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Measuring Blood Sugar With Light
2. Severe Low Blood Sugar Occurs Often in Patients With Type 2 Diabetes
3. In Preventing Diabetes-Related Heart Disease, Blood Pressure and Cholesterol Targets are Higher Priorities than Blood Sugar
4. Phase 3 Results Show Canagliflozin as Add-On Therapy to Metformin and Pioglitazone Significantly Lowers Blood Sugar Levels in Adult Patients with Type 2 Diabetes
5. Professor Releases Weight Management and Healthy Blood Sugar Control Products
6. In Pilot Study, a Peptide Controls Blood Sugar in People with Congenital Hyperinsulinism
7. JACO WS-14 Wall Mounted Tablet Security System Announcement
8. ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV
9. Par Pharmaceutical Begins Shipment of KHEDEZLA (desvenlafaxine) Extended-release Tablets, 50 mg and 100 mg
10. Sanofi US and POZEN Sign Exclusive License Agreement for the Commercialization of PA8140/PA32540 Tablets in the U.S.
11. Mylan Confirms Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg
Post Your Comments:
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... VIEW, Calif. , June 23, 2016 ... a.m. CST on Thursday, July 7, 2016 , , , ... ) , , , , EXPERT PANELISTS:  , ... Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa ... The global pharmaceutical industry is witnessing an ...
Breaking Medicine Technology:
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):